Abu Dhabi Biobank has partnered with AstraZeneca to leverage genomic research and clinical expertise to accelerate precision medicine and real-world healthcare innovation.
Abu Dhabi Biobank, a strategic initiative of the Department of Health – Abu Dhabi in collaboration with M42, has announced a new partnership with AstraZeneca to strengthen biomedical innovation in the region. The collaboration is aimed at advancing precision medicine and accelerating the translation of clinical research into everyday medical practice.
Also Read: Mouwasat Hospital Dammam Hosts Workshop on Advanced Airway Management
The partnership combines Abu Dhabi Biobank’s advanced biobanking capabilities and genomic infrastructure with AstraZeneca’s global expertise across cardiovascular, renal, metabolic, respiratory, immunology, and oncology therapeutic areas. Through this collaboration, both parties seek to convert complex biological data into practical healthcare solutions with the potential to significantly improve patient outcomes.
Commenting on the collaboration, Albarah ElKhani, Chief Operating Officer, Integrated Health Solutions, M42 said: “This collaboration represents more than a partnership; it is a shared vision to shape the future of medicine. By combining Abu Dhabi Biobank’s deep population insights and AstraZeneca’s scientific leadership, we are laying the foundation for breakthroughs that can redefine how diseases are understood, prevented and treated, particularly within the Middle Eastern population.”
Sameh ElFangary, Country President, Gulf and Pakistan, AstraZeneca, said: “Precision medicine can only succeed when it reflects the diversity of the world’s populations. Through our partnership with Abu Dhabi Biobank, we are combining world-class science with local data to enable earlier identification of at-risk patients particularly in rare and difficult-to-diagnose diseases and to help shape more personalized care pathways for the future. This collaboration marks an important step toward advancing equitable and data-driven healthcare for patients across our region and beyond.”
